Home
Conditions
Genital Neoplasms, Female

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,589 public trials 1,039 recruiting studies

Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer

NCT00030485

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

British Columbia Cancer Agency Vancouver, British Columbia, Canada

Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada

View Trial Details

Completed

Rapamycin With Grapefruit Juice for Advanced Malignancies

NCT00375245

Conditions: Adenoma, Adnexal Diseases, Breast Diseases, +73 more
Locations: University of Chicago Hospitals Chicago, Illinois, United States

View Trial Details

Completed

Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers

NCT00703807

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Yale University School of Medicine New Haven, Connecticut, United States

View Trial Details

Completed

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

NCT00085332

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States

CCOP - Western Regional, Arizona Phoenix, Arizona, United States

Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

Women's Cancer Center - Los Gatos Los Gatos, California, United States

View all 75 locations

View Trial Details

Completed

Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse

NCT00189553

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +16 more
Locations: Hôpital Hôtel Dieu Paris, France

View Trial Details

Completed

Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer

NCT01639885

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Leiden University Medical Center Leiden, Netherlands

View Trial Details

Completed

Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix

NCT00003065

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Herbert Irving Comprehensive Cancer Center at Columbia University New York, United States

View Trial Details

Completed

Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer

NCT00002894

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: Middlesex Hospital- Meyerstein Institute London, England, United Kingdom

View Trial Details

Completed

Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer

NCT00003749

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Medical Research Council Clinical Trials Unit London, England, United Kingdom

Royal Marsden NHS FoundationTrust - London London, England, United Kingdom

St. Mary's Hospital Manchester, England, United Kingdom

View Trial Details

Completed

CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

NCT00096239

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Genital Neoplasms, Female

Genital Neoplasms, Female trial results

Related conditions